Skip to Main Content


The research mission of YC-SCAN² is to promote study of the acute and chronic effects of cannabis and cannabinoids using a multi-pronged and multidisciplinary approach. YC-SCAN² intends to support groundbreaking molecular neuroscience, molecular genetics, electroencephalography, functional and neuroreceptor imaging, and psychopharmacology studies in the service of providing new insights to bridge the gap between basic and clinical research on cannabis and cannabinoids. Through an open competitive mechanism YC-SCAN² will support pilot projects submitted by Yale-affiliated investigators to collect pilot data towards developing larger funding applications to NIH and other funding agencies.

Clinical Trials